Cafepharma Today

January 17 2025 - Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
AstraZeneca overhauls management of its scandal-hit China division
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
Ozempic tops new Medicare price negotiation list
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

No Vindication For Vytorin; Victory for Sciele
CNBC
Tuesday, September 2, 2008 - 6:35pm
tags:
Eli Lilly says experimental blood thinner beat Plavix at stopping heart attacks in diabetics
Yahoo/AP
Tuesday, September 2, 2008 - 6:35pm
tags:
Japanese Drug Industry Makes Another Billion-Dollar U.S. Buy
WSJ Online
Tuesday, September 2, 2008 - 6:34pm
tags:
Gilead may shoot past big firms' buyout hunts
San Francisco Chronicle, CA
Tuesday, September 2, 2008 - 11:54am
tags:
Sciele Pharma Shares Jump On Merger Deal
Trading Markets
Tuesday, September 2, 2008 - 11:20am
tags:
Alpharma adopts poison-pill plan to head off hostile takoever by King Pharmaceuticals
Yahoo/AP
Tuesday, September 2, 2008 - 11:19am
tags:
Introgen's Advexin Gets FDA Snub
The Street.com
Tuesday, September 2, 2008 - 11:18am
tags:
Study: No proof Vytorin linked to cancer; other doctors warn it should be used carefully
Yahoo/AP
Tuesday, September 2, 2008 - 10:30am
tags:
New England Journal of Medicine: Vytorin-Cancer Link ‘Uncertain’
WSJ Online
Tuesday, September 2, 2008 - 10:27am
tags:
Eli Lilly says olanzapine study shows treatment benefit for up to six months
Trading Markets
Tuesday, September 2, 2008 - 10:24am
tags:
Glaxo heart drug seen promising despite trial miss
Forbes
Tuesday, September 2, 2008 - 10:23am
tags:
Novo Nordisk says to boost U.S. marketing
Guardian, UK
Tuesday, September 2, 2008 - 10:18am
tags:
Three Biotech Stocks That Could Double
The Street.com
Tuesday, September 2, 2008 - 10:17am
tags:
GlaxoSmithKline scales back relationship with Adolor
Bizjournals.com
Tuesday, September 2, 2008 - 10:12am
tags:
Glaxo Drug Misses Main Study Goal, Still Has Promise
Bloomberg
Tuesday, September 2, 2008 - 10:11am
tags:
U.K.'s SkyePharma Drops Most in 16 Years on Share-Sale Plan
Bloomberg
Tuesday, September 2, 2008 - 10:10am
tags:
Sciele a Buy Since January
Zacks.com
Tuesday, September 2, 2008 - 10:09am
tags:
Questions Arise Again on Vytorin Cancer Risk
CNBC
Tuesday, September 2, 2008 - 9:02am
tags:
Novacea to merge; Transcept to hold 60% of new firm
Marketwatch
Tuesday, September 2, 2008 - 9:00am
tags:
Boehringer Ingelheim: Phase III Dabigatran Data 2Q Or 3Q 09
CNN Money
Tuesday, September 2, 2008 - 8:59am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information